MedPath

Radiofrequency ablation for renal cell carcinoma using a switchin controller

Not Applicable
Conditions
renal cell carcinoma
Registration Number
JPRN-UMIN000002506
Lead Sponsor
Department of Radiology, Mie University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
33
Inclusion Criteria

Not provided

Exclusion Criteria

1. Abnormal coagulability a) platelet count of 50000/mm3 or less. b) INR greater than 1.5.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of adverse effects after radiofrequency ablation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath